Fig. 6.
Low TFAP2C expression is associated with poor prognosis. a The TFAP2C expression levels in 90 PDAC tissue samples and matched tumor-adjacent tissues evaluated by immunohistochemistry. Left pictures in each row are negative immunohistochemistry controls. b TFAP2C expression had a downward trend in PDAC tissues compared with tumor-adjacent tissues. c Kaplan-Meier survival analysis revealed that low TFAP2C expression levels in tumors were significantly associated with reduced survival in PDAC patients